Similar Articles
341 Network meta-analysis of the prognosis of curative treatment strategies for recurrent hepatocellular carcinoma after hepatectomy
342 Current status and prospect of treatments for recurrent hepatocellular carcinoma
343 Type 2 diabetes mellitus characteristics affect hepatocellular carcinoma development in chronic hepatitis B patients with cirrhosis
344 Immunotherapy for hepatocellular carcinoma: Current status and future perspectives
345 Efficacy of dexamethasone and N-acetylcysteine combination in preventing post-embolization syndrome after transarterial chemoembolization in hepatocellular carcinoma
346 Treatment of recurrent hepatocellular carcinoma following liver resection, ablation or liver transplantation
347 Postoperative adjuvant therapy for hepatocellular carcinoma with microvascular invasion
348 Impact of body mass index in elderly patients treated with laparoscopic liver resection for hepatocellular carcinoma
349 Application of ablative therapy for intrahepatic recurrent hepatocellular carcinoma following hepatectomy
350 Prognostic role of ring finger and WD repeat domain 3 and immune cell infiltration in hepatocellular carcinoma
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA